Skip to main content

French pharmaceutical giant Sanofi plans to pay up to $1.2B to buy a Peninsula cancer drug developer

Amunix's technology helps drugs stay longer in patients' bodies, and could be useful in conjunction with Sanofi's cancer drugs.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.